Hope.
Objective response was seen in 16% of mM patients (6% complete and 10% partial responders) and in 15% of mRCC patients (7% complete and 8% partial responders).
Objective response was seen in 16% of mM patients (6% complete and 10% partial responders) and in 15% of mRCC patients (7% complete and 8% partial responders).

FIGHT.
Proleukin helps your immune system by boosting its natural defenses against cancer.
Consider treatment with Proleukin.
FREEDOM.
Proleukin leaves your options open to receive other cancer therapies.
Ask about immunotherapy with Proleukin.

How Proleukin May Help
With Proleukin, some people have had their cancer tumors completely disappear for over 20 years.

Is Proleukin Right for You?
If you do not have any other serious health issues, ask your doctor if Proleukin may be a treatment option for you.

Learn about Bruce’s Proleukin experience
Actual metastatic melanoma survivor*
Diagnosed with metastatic melanoma in 2006, Bruce had tumors in his hips and spine, and “innumerable tumors” on his liver.† Thanks to Proleukin, he’s now cancer-free. “Treatment with Proleukin is not fun,” says Bruce. "My body swelled and puffed up, which was caused by capillary leakage. Then I had diarrhea and nausea, and, toward the end of the treatment period, mental fatigue set in. But the nurses anticipated and expected each of my side effects. I had a PET scan about 6 weeks after starting. All the tumors were gone. The doctor was stunned. I was stunned. When I started treatment I really just wanted to get back to my life. That’s what I hoped would happen. And that’s what happened.”
- Bruce is a real person who has been cancer-free since 2006. His experience isn’t representative of overall results with Proleukin. In Proleukin clinical studies, about 1 in 17 people with metastatic melanoma had no evidence of disease, ranging from 3 months to 10+ years. Objective response was seen in 16% of patients with metastatic melanoma (6% had a complete response and 10% had a partial response). Individual results may vary.

Learn about Peggy’s Proleukin experience
Actual metastatic kidney cancer survivor*

Diagnosed with metastatic kidney cancer in 2004, Peggy had a 10-centimeter tumor and hundreds of metastases in her lungs.‡ “It was devastating,” says Peggy. Thanks to treatment with Proleukin, she has been cancer-free since 2005. “The journey wasn’t easy.” Peggy remembers little of the treatment week, her memory was muddy, and she just knew that she had been terribly sick, but that she was taken care of by the hospital staff. “People have asked me ‘would you do Proleukin again?’ And the answer is always ‘in a heartbeat.’ I’ve been officially cleared of any metastases. I live a perfectly energetic, healthy life. I get to travel. I have grandkids overseas. Proleukin saved my life.”
- Peggy is a real person who has been cancer-free since 2005. Her experience isn’t representative of overall results with Proleukin. In Proleukin clinical studies, about 1 in 15 people with metastatic kidney cancer had no evidence of disease, ranging from 7 months to 10+ years. Objective response was seen in 15% of patients with metastatic kidney cancer (7% had a complete response and 8% had a partial response). Individual results may vary.

Find an Expert Treatment Center
If you and your doctor are considering Proleukin, connect with healthcare professionals who are dedicated to caring for you throughout your treatment.